Health and Media Minister Dr. Nalinda Jayatissa directed the newly appointed members of the Ayurvedic Drug and Product Regulatory Council to ...

The National Medicines Regulatory Authority (NMRA) has started verifying prices directly with global pharmaceutical manufacturers whenever it notices significant discrepancies between the rates quoted ...

If approved by the EMA, mavorixafor would be the first drug indicated for patients with WHIM syndrome in Europe, a population ...

EMA validates X4 Pharma’s marketing authorization application for mavorixafor to treat WHIM syndrome: Boston Monday, January 27, 2025, 11:00 Hrs [IST] X4 Pharmaceuticals, a comp ...

Trusted source of information on Environmental Health that includes articles, news, videos, animations, quizzes, calculators ...

Following the licensing agreement with X4 Pharmaceuticals, Norgine is pleased to see the announcement from X4 today that their Marketing Authorization Application (MAA) for ...

Portfolio Receipts of $742 million in Q4 2024 and $2,801 million for FY 2024Royalty Receipts growth of 12% in Q4 2024 and 13% for FY 2024 Net ...

Doctors who were dragged into the Dengvaxia cases are hoping to get justice through the ongoing evaluation conducted by the ...

SHELTON, CT / ACCESS Newswire / February 11, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") declared today that it is ...

natural medicinal chemistry, etc, focusing on the areas of isolation, structural elucidation, biological evaluation, structure-activity relationship, and mechanism, yield improvement of bioactive ...

The doctors who were dragged into the Dengvaxia cases remain hopeful that their pending cases will be dismissed after the ...